MBS2320

DRUG3 trials

Sponsors

Modern Biosciences Limited, Modern Biosciences Limited, Modern Biosciences Ltd

Conditions

Arthritis, RheumatoidIdiopathic Pulmonary FibrosisRheumatoid Arthritis

Phase 1

Safety and Tolerability Study of MBS2320 in Healthy Subjects and Subjects With Rheumatoid Arthritis

CompletedNCT02480946

Modern Biosciences LtdArthritis, Rheumatoid

Start: 2015-07-31End: 2017-03-31Updated: 2017-03-28

Phase 2

Safety, Tolerability and Efficacy of MBS2320 in Patients With Rheumatoid Arthritis

CompletedNCT03139136

Modern Biosciences LtdRheumatoid Arthritis

Start: 2017-05-30End: 2019-08-13Updated: 2019-08-14

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Efficacy and Safety of MBS2320 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

CompletedCTIS2023-504418-30-00

Modern Biosciences Limited, Modern Biosciences LimitedIdiopathic Pulmonary Fibrosis

Start: 2023-10-24End: 2024-03-14Target: 156Updated: 2023-12-05